Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 23, 2026

Back to today

From X

@StableBread

Fajasy on X

Excluding medical isotopes, commercial power revenue at BWX Technologies $BWXT nearly tripled, from ~$400M in 2023 to ~$1.1B expected in 2026. $BWXT’s commercial segment is growing much faster than its government segment, driven by (1) Ontario rebuilding its reactors, (2) Canada’s plan for new ones, and (3) the U.S. push for new AP1000 reactors. Its commercial backlog more than doubled to $1.6B. Kinectrics, a Toronto-based nuclear engineering and testing firm acquired in May 2025, explains part of the jump. Commercial revenue grew 72% in Q2 2026, or 33% excluding the acquisition. In Ontario, utilities are rebuilding reactors to run for decades longer. $BWXT is building 48 steam generators for Ontario Power Generation’s (OPG) Pickering refurbishment, part of more than CAD$1B (~$700M) of contracts. The same contracts cover the reactor pressure vessel for the first BWRX-300 at OPG’s Darlington station, a 300 MWe small modular reactor (SMR) designed by GE Vernova Hitachi. The 10-K calls $BWXT “the only commercial heavy nuclear component manufacturer in North America.” Notably, its Cambridge, Ontario plant is turning out more than 1.5 steam generators/month vs. the 1/month its schedule requires, per $BWXT’s Investor Day on September 29, 2026. Beyond refurbishments, Canada’s June 2026 nuclear strategy calls for “up to ten new large-scale reactors,” with two under construction by 2035 and five more planned or under development by 2040. $BWXT already has licensing and early engineering contracts for the large reactors planned by OPG and Bruce Power, the private operator of Ontario’s Bruce nuclear station. John MacQuarrie, president of Commercial Operations, estimated Canada’s new-build market at CAD$120-150B (~$84-105B) at Investor Day. Slide 31 shows $BWXT’s potential revenue per new reactor: → CANDU (Canada’s heavy-water reactor design): $350-700M per reactor. → AP1000 (Westinghouse’s large U.S. design): Low hundreds of millions of dollars. → SMRs: $50-100M.

Investor Letters

All letters

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $34B
Net Interest 8 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B
Best Anchor Stocks 12 clicks
PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $103M
Value Investors Club

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 33 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 4 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $108M
Triple S Special Situations Investing 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 61 of 249

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.